awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-0B11354C-3D82-4285-9DA7-0ADF2D09E2C6
Q42720284-0B11354C-3D82-4285-9DA7-0ADF2D09E2C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-0B11354C-3D82-4285-9DA7-0ADF2D09E2C6
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P304
Q42720284-0B11354C-3D82-4285-9DA7-0ADF2D09E2C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-0B11354C-3D82-4285-9DA7-0ADF2D09E2C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de794169a8f7bb04f7552c33bb22286fcc60dfa
P304
4614-4618
http://www.w3.org/2001/XMLSchema#string